Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort

The Preserflo MicroShunt represents a novel glaucoma treatment device, necessitating long-term follow-up data to accurately assess its efficacy. The aim of this study is to report real-world data of a heterogenous glaucoma cohort who received Preserflo implantation at a specialized glaucoma clinic....

Full description

Bibliographic Details
Main Authors: Jens Julian Storp, Friederike Elisabeth Vietmeier, Ralph-Laurent Merté, Raphael Koch, Julian Alexander Zimmermann, Nicole Eter, Viktoria Constanze Brücher
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/13/4474